Robotic-assisted knee reconstruction has increased significantly over the past years as robots have become more popular in the operation room. The number of robotic-assisted knee reconstruction surgeries will reach approximately 700,000 globally by 2030, at a compound annual growth rate (CAGR) of 8% from 2021 to 2030, according to GlobalData, a leading data and analytics company.
According to GlobalData analysis, there are approximately three million knee reconstruction surgeries worldwide annually. In 2020, around 11% of the knee reconstruction surgeries were completed with the support of robotic assistance.
Tina Deng, MSc, Principal Medical Devices Analyst at GlobalData, comments: “In comparison with a conventional procedure, robotic total knee surgery improves surgeons’ consistency and accuracy to control implant positioning, ligament balance, and limb alignment, leading to decreased postoperative pain, a shorter stay in the hospital, and better knee flexion on discharge. Despite the drawbacks such as a learning curve, the financial costs, and lack of long-term clinical data, most joint reconstruction surgeons support the usage of orthopedic robots to improve precision and short-term patient outcomes in knee reconstruction surgeries.
“The most popular surgical robots for knee reconstruction include Stryker Mako, Zimmer Biomet ROSA Knee, Smith & Nephew CORI, and newly approved Johnson & Johnson VELYS, controlling over 95% of the knee robots market in the US. All the robots are compatible only with partial and/or total knee implants from the same manufacturer. Therefore, more installed bases of knee robots mean more potential shares in the knee implants market. It can be expected the competition among major players will be more intense by racing in both capital equipment and consumable markets.”
